Introduction
Zika virus (ZIKV) is a member of the Spondweni serocomplex within the genus Flavivirus firstly isolated in 1947 from a sentinel rhesus monkey in Zika Forest, Uganda [1] . There are two main lineages of ZIKV, the African and the Asian lineages [2, 3] .
ZIKV was until recently considered a mildly pathogenic mosquito-borne flavivirus with very few reported human cases of self-limiting acute febrile illnesses most often with maculopapular rash, headache, arthralgia, myalgia and conjunctivitis [4] [5] [6] . In 2007, after an epidemic in Micronesia [7, 8] the geographic range of ZIKV expanded dramatically. In 2013-2014, through an outbreak in French Polynesia a link relating ZIKV infections with the increased incidence of Guillan-Barré syndrome and other neurological complications was assumed mainly in regions with previous dengue epidemics [9, 10] . The potential association with congenital microcephaly cases in Brazil 2015 [11, 12] , still under investigation, raise several questions, that undoubtedly increase public health awareness to ZIKV, and led the WHO declaration, considering ''the recent cluster of microcephaly cases and other neurological disorders reported in Brazil, following a similar cluster in French Polynesia'' a Public Health Emergency of International Concern on February 1, 2016 [13] . As most pathogenic flavivirus, only a small percentage of ZIKV cases (estimated to be about 25%) are symptomatic [8] , and transmission via transfusion of infected blood or organs donations, or sexual transmission, remains a risk.
Here we report four cases of patients with Zika infection, diagnosed in Portugal, shortly after returning from Brazil. In June 2015, Zika virus infection was serologically detected for the first time in a couple returning from Ceará state and in the end of 2015, Zika virus was detected in the urine samples of two patients after visiting Rio de Janeiro and Espírito Santo states.
Case presentation

Cases 1 and 2
In June 2015, a Portuguese couple in their sixties with no past medical history, traveled to northeast Brazil (Ceará State) on holidays for two weeks. At midstay (day 1 of illness) both developed fever (38.3 8C) and arthralgias. The fever lasted for three days, responding to acetaminophen and ibuprofen. Arthralgias were located in the hands, wrists and ankles, lasting till admission. At day 4, they complained of macular rash with no pruritus, predominantly on the lower limbs in the woman, and on the trunk in the man. Both reported anorexia with weight loss and the man felt asthenic. Upon admission in Portugal, on day 11 of illness, they both appeared sick and tired with dry mucosae and lower extremity rashes below the knee. The laboratory findings in the hospital were within normal limits, except for C-reactive protein 10.6 mg/L (norm: <5 mg/L) and slightly elevated aminotransferase, ALT 58 U/ L for the man and 52 U/L for the woman (norm: 4-50 U/L). Specific diagnostic was requested for Dengue, Zika and Chikungunya viruses. Serology was IgM positive for Zika virus in both patients. The patients recovered without complications.
Case 3
A 62 year old Brazilian woman, with a past medical history of systemic lupus erythematosus, fibromyalgia, cardiomyopathy and hyperuricemia who had lived in Portugal for the last 15 years, developed fever, myalgias and arthralgias on November 22 2015 after a month trip to Rio de Janeiro and Espírito Santo states (southeast Brazil). The next day, she developed a maculopapular rash, more prominent on the forearms and thighs with mild conjunctival hyperemia. In the ER, on the fourth day of illness, she was afebrile and hemodynamically stable. Basic laboratory workup did not revealed leukopenia, thrombocytopenia or abnormal liver enzymology. The fever continued for eight days in total, with bi-daily peaks. The rash remained from the second to the sixth day of illness, as well as myalgias. Differential serological diagnosis was requested for Trypanosoma sp., Chikungunya, Dengue and Zika viruses. The serology (ELISA) for Trypanosoma sp. was negative. Real-time PCR in urine and IgG serology were positive for Zika virus.
The patient had only symptomatic treatment with paracetamol and full recovery without sequel. She kept her long term medication with chloroquine sulphate, digoxin, candesartan, carvedilol, furosemide, trazodone, duloxetine and alopurinol.
Case 4
A 57 year old Portuguese man, with no past medical history, presented on December 7 2015 complaining of chills, generalized asthenia and myalgia and rash, one day after returning from Rio de Janeiro after a 10 day stay. The study in the hospital revealed thrombocytopenia (126 000/mL), without leukopenia or abnormal liver enzymology. Real-time PCR was positive for Zika virus in the urine sample. The patient received supportive treatment, improving clinically to symptoms free.
Previous flavivirus infections and vaccination against flaviviruses (yellow fever, tick-borne encephalitis and Japanese encephalitis viruses) were not reported by any of the patients. The data of these four imported cases to Portugal is summarized in Table 1 .
Molecular and serologic diagnostics
In the National Institute of Health, sera samples were tested by immunofluorescent assay (IFA) in-house (IgG and IgM) for Zika virus (ZIKV), Dengue (DENV) and Chikungunya viruses (CHIKV) ( Table 1 ). The presence of immunoglobulins specific to other flaviviruses, such as yellow fever (YFV), tick-borne encephalitis (TBEV) and West Nile (WNV) viruses was also tested by IFA and all assay results were negative for IgM and presented cross-reaction signals in IgG.
Nucleic acids were extracted from 400 mL of ethylenediaminetetraacetic acid (EDTA) blood samples and 900 mL urine samples using NucliSens easyMAG platform (BioMé rieux). The presence of ZIKV RNA was checked by real-time RT-PCR [14] and conventional reverse transcription-polymerase chain reaction (RT-PCR) using Zika specific primers [15] and pan-flavivirus primers [16] targeting the non-structural protein 5 (NS5) gene. The presence of DENV and CHIKV RNA was checked by real-time PCR as reported previously [16] , and by conventional RT-PCR [17] , respectively. For cases 1 and 2, Zika RT-PCR was negative (conventional and real time RT-PCR) on blood samples collected on day 13 post onset of disease. For cases 3 and 4, real time RT-PCR and conventional RT-PCR were positive in urine samples on day 8 and 9 post onset, respectively. The nested-PCR fragments (overlapping NS5, 205 bp) was sequenced bi-directionally and submitted to GenBank (accession numbers KU752544 and KU752545). Similarity searches were made within the GenBank data set using the basic local alignment search tool (BLAST) BLASTN algorithm [18] . Maximum likelihood analysis was performed with Kimura two-parameter model with invariant sites using Mega version 6 software [19] . The robustness of the nodes was tested by 1000 bootstrap replications.
Discussion
In the reported cases 1 and 2, although not confirmed by molecular detection, the compatible clinical criteria, the presence of IgM only for ZIKV, and the observed seroconversion (although not with a four-fold or greater change antibody titers in paired sera) proves the detection of two primary flavivirus infections. Zika virus infection in case 3 was evident by the positive urine sample by PCR identified as belonging to the Asian lineage (Fig. 1) . This was the first analyzed PCR positive sample in the laboratory and the only ZIKV strain previously worked (MR 766) belongs to the African lineage, ruling out any possibility of PCR contamination. Besides the molecular diagnosis, the serological results with high positive IgG values (262,144 for ZIKV and 131,072 for DENV; cutoff = 32) and negative IgM titers (cut-off = 16), strongly suggest a secondary infection by ZIKV after a probable primary DENV infection. Cross-reaction IgG antibody titers were much lower for other flaviviruses (4096 for YFV, TBEV and WNV). In case 4 the first sample, RT-PCR for ZIKV was positive in urine (9 days post onset) and negative in blood. Seroconversion was observed in the second and third samples, firstly by only IgM positive detection (11 days post onset) followed by IgG detection (52 days post onset).
Clinicians' awareness in including Zika virus, along with dengue and chikungunya viruses in differential diagnoses to patients with febrile syndromes and rash with compatible travel history is vital to enhanced vigilance and promptly detect ZIKV imported cases. On the other hand, as previously noted [20] , although imported Zika infection in returned travelers is usually mild, the possibility of sexual transmission and the eventual association with several congenital malformations and microcephaly, still under investigation, raises concern among pregnant and fertile female travelers. Proper advice regarding diagnosis should be provided to pregnant women, as proper perinatal care to all who test positive for Zika virus.
Conclusion
The rapid and ongoing spread of ZIKV in the Americas and South Pacific increases the ZIKV importation in the EU and the risk of autochthonous transmission in regions where Aedes mosquitoes are establish. In Portugal, this risk is increased given the historical relations between Portugal and Brazil with high trade and travel. Madeira Island is the only region in the EU with established population of Aedes aegypti where it was detected for the first time in 2004. In 2012 a dengue outbreak was reported in Madeira [16] most likely imported from Venezuela that is also one of the countries with ongoing Zika outbreak.
The potential epidemiological association of ZIKV infection with severe complications in regions with previous DENV epidemics as Madeira Island and the future increase of imported Zika cases to Europe urge to enhance vector surveillance and awareness among health professionals in this region.
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